GALD ASSAY Trademark

Trademark Overview

On Friday, June 9, 2023, a trademark application was filed for GALD ASSAY with the United States Patent and Trademark Office. The USPTO has given the GALD ASSAY trademark a serial number of 98035977. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Monday, June 23, 2025. This trademark is owned by Reliant Glycosciences, LLC. The GALD ASSAY trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic assays for testing serum levels of Gd-IgA1 biomarker present in IgA nephropathy
gald assay

General Information

Serial Number98035977
Word MarkGALD ASSAY
Filing DateFriday, June 9, 2023
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateMonday, June 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic assays for testing serum levels of Gd-IgA1 biomarker present in IgA nephropathy
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLEASSAY

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 23, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameReliant Glycosciences, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBirmingham, AL 35242

Trademark Events

Event DateEvent Description
Tuesday, June 13, 2023NEW APPLICATION ENTERED
Thursday, July 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 29, 2024ASSIGNED TO EXAMINER
Thursday, June 6, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, June 6, 2024PETITION TO REVIVE-GRANTED
Monday, March 4, 2024NON-FINAL ACTION WRITTEN
Monday, March 4, 2024NON-FINAL ACTION E-MAILED
Monday, March 4, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 6, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, June 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 30, 2024ASSIGNED TO LIE
Thursday, October 31, 2024NON-FINAL ACTION WRITTEN
Thursday, October 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 31, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 18, 2025ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, February 18, 2025ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 1, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 1, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 1, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 1, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 1, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 23, 2025PETITION TO REVIVE-GRANTED
Monday, June 23, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, June 23, 2025NOTICE OF REVIVAL - E-MAILED
Monday, June 23, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 23, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 23, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

assay gald biomarker present nephropathy levels serum diagnostic assays testing medical